M. Feldmann, R. Williams, and E. Paleolog, What have we learnt from targeted anti-TNF therapy?, Annals of the Rheumatic Diseases, vol.69, issue.Suppl 1, pp.97-106, 2010.
DOI : 10.1136/ard.2009.117143

J. Smolen and D. Aletaha, Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges, Nature Reviews Rheumatology, vol.20, issue.5, pp.276-89, 2015.
DOI : 10.1016/S0140-6736(12)61811-X

T. Horiuchi, H. Mitoma, S. Harashima, H. Tsukamoto, and T. Shimoda, Transmembrane TNF-??: structure, function and interaction with anti-TNF agents, Rheumatology, vol.49, issue.7, pp.1215-1243, 2010.
DOI : 10.1093/rheumatology/keq031

K. Juhasz, K. Buzas, and E. Duda, Importance of reverse signaling of the TNF superfamily in immune regulation, Expert Review of Clinical Immunology, vol.9, issue.4, pp.335-383, 2013.
DOI : 10.1586/eci.13.14

G. Eissner, W. Kolch, and P. Scheurich, Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system, Cytokine & Growth Factor Reviews, vol.15, issue.5, pp.353-66, 2004.
DOI : 10.1016/j.cytogfr.2004.03.011

G. Eissner, S. Kirchner, H. Lindner, W. Kolch, P. Janosch et al., Reverse Signaling Through Transmembrane TNF Confers Resistance to Lipopolysaccharide in Human Monocytes and Macrophages, The Journal of Immunology, vol.164, issue.12, pp.6193-6201, 2000.
DOI : 10.4049/jimmunol.164.12.6193

U. Meusch, M. Rossol, C. Baerwald, S. Hauschildt, and U. Wagner, Outside-to-inside signaling through transmembrane tumor necrosis factor reverses pathologic interleukin-1?? production and deficient apoptosis of rheumatoid arthritis monocytes, Arthritis & Rheumatism, vol.100, issue.Pt 1, pp.2612-2633, 2009.
DOI : 10.1002/art.24778

J. Davignon, M. Hayder, M. Baron, J. Boyer, A. Constantin et al., Targeting monocytes/macrophages in the treatment of rheumatoid arthritis, Rheumatology, vol.52, issue.4, pp.590-598, 2013.
DOI : 10.1093/rheumatology/kes304

J. Boyer, P. Balard, H. Authier, B. Faucon, J. Bernad et al., Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes, Arthritis Research & Therapy, vol.9, issue.2, p.22, 2007.
DOI : 10.1186/ar2133

S. Papaiahgari, S. Kleeberger, H. Cho, D. Kalvakolanu, and S. Reddy, NADPH Oxidase and ERK Signaling Regulates Hyperoxia-induced Nrf2-ARE Transcriptional Response in Pulmonary Epithelial Cells, Journal of Biological Chemistry, vol.279, issue.40, pp.42302-42314, 2004.
DOI : 10.1074/jbc.M408275200

D. Burdette, M. Olivarez, and G. Waris, Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway, Journal of General Virology, vol.91, issue.3, pp.681-90, 2009.
DOI : 10.1099/vir.0.014340-0

A. Brewer, T. Murray, M. Arno, M. Zhang, N. Anilkumar et al., Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo, Free Radical Biology and Medicine, vol.51, issue.1, pp.205-220, 2011.
DOI : 10.1016/j.freeradbiomed.2011.04.022

A. Kobayashi, M. Kang, H. Okawa, M. Ohtsuji, Y. Zenke et al., Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2, Molecular and Cellular Biology, vol.24, issue.16, pp.7130-7139, 2004.
DOI : 10.1128/MCB.24.16.7130-7139.2004

B. Segal, W. Han, J. Bushey, M. Joo, Z. Bhatti et al., NADPH Oxidase Limits Innate Immune Responses in the Lungs in Mice, PLoS ONE, vol.5, issue.3, p.9631, 2010.
DOI : 10.1371/journal.pone.0009631.g010

D. Olagnier, R. Lavergne, E. Meunier, L. Lefevre, C. Dardenne et al., Nrf2, a PPAR?? Alternative Pathway to Promote CD36 Expression on Inflammatory Macrophages: Implication for Malaria, PLoS Pathogens, vol.5, issue.9, p.1002254, 2011.
DOI : 10.1371/journal.ppat.1002254.s006

T. Ishii, K. Itoh, E. Ruiz, D. Leake, H. Unoki et al., Role of Nrf2 in the Regulation of CD36 and Stress Protein Expression in Murine Macrophages: Activation by Oxidatively Modified LDL and 4-Hydroxynonenal, Circulation Research, vol.94, issue.5, pp.609-625, 2004.
DOI : 10.1161/01.RES.0000119171.44657.45

R. Thimmulappa, H. Lee, T. Rangasamy, S. Reddy, M. Yamamoto et al., Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis, Journal of Clinical Investigation, vol.116, issue.4, pp.984-95, 2006.
DOI : 10.1172/JCI25790DS1

C. Wruck, A. Fragoulis, A. Gurzynski, L. Brandenburg, Y. Kan et al., Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice, Annals of the Rheumatic Diseases, vol.70, issue.5, pp.844-50, 2011.
DOI : 10.1136/ard.2010.132720

J. Alam, D. Stewart, C. Touchard, S. Boinapally, A. Choi et al., Nrf2, a Cap'n'Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene, Journal of Biological Chemistry, vol.274, issue.37, pp.26071-26079, 1999.
DOI : 10.1074/jbc.274.37.26071

S. Ryter and A. Choi, Heme Oxygenase-1/Carbon Monoxide: Novel Therapeutic Strategies in Critical Care Medicine, Current Drug Targets, vol.11, issue.12, pp.1485-94, 2010.
DOI : 10.2174/1389450111009011485

K. Poss and S. Tonegawa, Reduced stress defense in heme oxygenase 1-deficient cells, Proceedings of the National Academy of Sciences, vol.94, issue.20, pp.10925-10955, 1997.
DOI : 10.1073/pnas.94.20.10925

A. Yachie, Y. Niida, T. Wada, N. Igarashi, H. Kaneda et al., Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency, Journal of Clinical Investigation, vol.103, issue.1, pp.129-164, 1999.
DOI : 10.1172/JCI4165

A. Kinderlerer, P. Gregoire, I. Hamdulay, S. Ali, F. Steinberg et al., Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin, Blood, vol.113, issue.7, pp.1598-607, 2009.
DOI : 10.1182/blood-2008-04-152934

A. Paine, B. Eiz-vesper, R. Blasczyk, and S. Immenschuh, Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential, Biochemical Pharmacology, vol.80, issue.12, pp.1895-903, 2010.
DOI : 10.1016/j.bcp.2010.07.014
URL : https://hal.archives-ouvertes.fr/hal-00637151

A. Nesbitt, G. Fossati, M. Bergin, P. Stephens, S. Stephens et al., Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor ?? agents, Inflammatory Bowel Diseases, vol.13, issue.11, pp.1323-1355, 2007.
DOI : 10.1002/ibd.20225

K. Bedard and K. Krause, The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology, Physiological Reviews, vol.87, issue.1, pp.245-313, 2007.
DOI : 10.1152/physrev.00044.2005

C. Riganti, E. Gazzano, M. Polimeni, C. Costamagna, A. Bosia et al., Diphenyleneiodonium Inhibits the Cell Redox Metabolism and Induces Oxidative Stress, Journal of Biological Chemistry, vol.279, issue.46, pp.47726-47757, 2004.
DOI : 10.1074/jbc.M406314200

T. Yamamori, O. Inanami, H. Nagahata, and M. Kuwabara, Phosphoinositide 3-kinase regulates the phosphorylation of NADPH oxidase component p47phox by controlling cPKC/PKC?? but not Akt, Biochemical and Biophysical Research Communications, vol.316, issue.3, pp.720-750, 2004.
DOI : 10.1016/j.bbrc.2004.02.108

S. Kirchner, S. Boldt, W. Kolch, S. Haffner, S. Kazak et al., LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF)

X. Wang, H. Kim, K. Nakahira, S. Ryter, and A. Choi, The Heme Oxygenase-1/Carbon Monoxide Pathway Suppresses TLR4 Signaling by Regulating the Interaction of TLR4 with Caveolin-1, The Journal of Immunology, vol.182, issue.6, pp.3809-3827, 2009.
DOI : 10.4049/jimmunol.0712437

X. Kong, R. Thimmulappa, P. Kombairaju, and S. Biswal, NADPH Oxidase-Dependent Reactive Oxygen Species Mediate Amplified TLR4 Signaling and Sepsis-Induced Mortality in Nrf2-Deficient Mice, The Journal of Immunology, vol.185, issue.1, pp.569-77, 2010.
DOI : 10.4049/jimmunol.0902315

S. Rushworth, S. Shah, and D. Macewan, TNF Mediates the Sustained Activation of Nrf2 in Human Monocytes, The Journal of Immunology, vol.187, issue.2, pp.702-709, 2011.
DOI : 10.4049/jimmunol.1004117

M. Locati, A. Mantovani, and A. Sica, Macrophage Activation and Polarization as an Adaptive Component of Innate Immunity, Adv Immunol, vol.120, pp.163-84, 2013.
DOI : 10.1016/B978-0-12-417028-5.00006-5

J. Huang, J. Welch, M. Ricote, C. Binder, T. Willson et al., Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase, Nature, vol.400, issue.6742, pp.378-82, 1999.

J. Kim, Y. Cha, and Y. Surh, A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.690, issue.1-2, pp.12-23, 2010.
DOI : 10.1016/j.mrfmmm.2009.09.007

T. Khor, M. Huang, K. Kwon, J. Chan, B. Reddy et al., Nrf2-Deficient Mice Have an Increased Susceptibility to Dextran Sulfate Sodium-Induced Colitis, Cancer Research, vol.66, issue.24, pp.11580-11584, 2006.
DOI : 10.1158/0008-5472.CAN-06-3562

Y. Kirino, M. Takeno, S. Murakami, M. Kobayashi, H. Kobayashi et al., Tumor necrosis factor ?? acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes, Arthritis & Rheumatism, vol.24, issue.2, pp.464-75, 2007.
DOI : 10.1002/art.22370

F. Rousset, M. Nguyen, L. Grange, F. Morel, and B. Lardy, Heme Oxygenase-1 Regulates Matrix Metalloproteinase MMP-1 Secretion and Chondrocyte Cell Death via Nox4 NADPH Oxidase Activity in Chondrocytes, PLoS ONE, vol.152, issue.6, p.66478, 2013.
DOI : 10.1371/journal.pone.0066478.s007

P. Chi, C. Liu, I. Lee, Y. Chen, L. Hsiao et al., HO-1 induction by CO-RM2 attenuates TNF-alpha-induced cytosolic phospholipase A2 expression via inhibition of PKCalpha-dependent NADPH oxidase/ROS and NF-kappaB, Mediators Inflamm, vol.2014, p.279171, 2014.

A. Pallai, B. Kiss, G. Vereb, M. Armaka, G. Kollias et al., Transmembrane TNF-?? Reverse Signaling Inhibits Lipopolysaccharide-Induced Proinflammatory Cytokine Formation in Macrophages by Inducing TGF-??: Therapeutic Implications, The Journal of Immunology, vol.196, issue.3, pp.1146-57, 2016.
DOI : 10.4049/jimmunol.1501573